Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.27 USD | +5.24% | +12.25% | -10.34% |
05-08 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
05-08 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.34% | 2.61B | |
+5.15% | 109B | |
+11.65% | 105B | |
-0.06% | 22.25B | |
-12.18% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.79% | 16.85B | |
+4.80% | 13.76B | |
+35.30% | 12.46B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Citigroup Initiates Denali Therapeutics With Buy Rating, Price Target is $32